Autologous/Allogeneic TGF-beta-resistant LMP-specific CTLs

· Baylor College of Medicine

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Autologous/Allogeneic TGF-beta-resistant LMP-specific CTLs, covering 2025-10-31 to 2025-10-31. Get the full timeline:

Most recent: Clinical Trial Update: Autologous/Allogeneic TGFbeta-resistant LMP-specific CTL, Lymphoma (TGF-beta) [Phase 1]

See pricing